New patent for Optinose Us drug XHANCE

Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are sixteen patents protecting this drug. XHANCE drug…
The post New patent for Optinose Us drug XHANCE appeared first on DrugPatent…

The post New patent for Optinose Us drug XHANCE appeared first on Biotechblog.

Published on Fri, 25 Sep 2020 00:09:37 +0000 and made possible by power apps encode string